leadf
logo-loader
viewVisioneering Technologies
(
ASX:VTI
)

Visioneering Technologies seeing 'consistent, very strong growth' each quarter

Visioneering Technologies (ASX:VTI) executive director & CEO Stephen Snowdy speaks to Proactive Investors about the US-based medical device company's revolutionary Natural VUE multifocal contact lenses for children with myopia and adults with presbyopia.

The vertically integrated company has recently grown its sales team in the US, and now has a large accounts base to leverage increased revenues from. Earlier this year, Visioneering Technologies obtained approvals to market its existing products in Europe, and Australia and New Zealand. Those international launches will happen this year, whilst new product releases are slated for 2019.

Quick facts: Visioneering Technologies

Follow
ASX:VTI

Price: 0.965 AUD

Market Cap: $22.81 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Cipherpoint fully-focused on services and recurring revenue following...

Cipherpoint Ltd (ASX:CPT)'s Ted Pretty speaks to Proactive's Andrew Scott following the news it's sold its cp.protect and cp.discover technology assets to fellow ASX-lister archTIS Ltd. As part of the purchase agreement, archTIS is offering $1.4 million in cash for the Cipherpoint software...

15 hours, 18 minutes ago

2 min read